Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleRE: Final Overall Survival: Fulvestrant 500 mg vs 250 mg in the Randomized CONFIRM Trial.AuthorsMartin, Miguel; Boyer, John; Stuart, Mary; di Leo, AngeloSubjectsBREAST cancer treatment; DOSE-effect relationship in pharmacology; PROGRESSION-free survivalPublicationJNCI: Journal of the National Cancer Institute, 2017, Vol 109, Issue 3, p1ISSN0027-8874Publication typejournal articleDOI10.1093/jnci/djw234